BiotechTube
FemCap

FemCap

Los Angeles, United States· Est.
femcap.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

FemCap is a long-standing private company commercializing a single, FDA-approved medical device: a non-hormonal cervical cap for contraception. Its strategy leverages direct-to-consumer e-commerce and telehealth for sizing and distribution, targeting women seeking alternatives to hormonal birth control and emphasizing autonomy, comfort, and environmental sustainability. The company's commercial success hinges on effective digital marketing, user education, and competing within the niche but growing market for non-hormonal, user-controlled contraceptive methods.

Women's HealthContraception

Technology Platform

Design and manufacture of a reusable, silicone cervical barrier contraceptive device with ergonomic features and a removal strap.

Opportunities

Growing consumer demand for non-hormonal, user-controlled, and eco-friendly contraceptive options presents a significant expansion opportunity.
Effective use of social media and direct-to-consumer telehealth can bypass traditional healthcare channels and drive rapid user acquisition.
The reusable nature of the product offers a compelling cost-saving and sustainability narrative in a value-conscious market.

Risk Factors

The product's efficacy is highly user-dependent, with typical-use rates lower than leading hormonal and long-acting reversible contraceptives (LARCs), posing a challenge for widespread adoption.
The company faces intense competition from both established pharmaceutical giants and new femtech startups.
Reliance on a single product line creates significant business concentration risk.

Competitive Landscape

FemCap competes in the barrier method segment against the diaphragm (Caya) and the contraceptive sponge (Today Sponge). Its primary competition is the broader contraceptive market, dominated by highly effective hormonal methods (pills, patches, rings, hormonal IUDs like Mirena) and non-hormonal LARCs (copper IUDs like Paragard). It must differentiate on its hormone-free, reusable, and patient-controlled value proposition.

More companies in Drug Delivery & Formulation →More companies in United States →